Literature DB >> 22379151

Octreotide treatment of idiopathic pulmonary fibrosis: a proof-of-concept study.

B Crestani, J Chapron, B Wallaert, E Bergot, P Delaval, D Israel-Biet, J Lacronique, I Monnet, M Reynaud-Gaubert, A Tazi, R Lebtahi, M-P Debray, M Brauner, M Dehoux, Q Dornic, M Aubier, F Mentré, X Duval.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22379151     DOI： 10.1183/09031936.00113011

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  5 in total

Review 1.  Imaging Pulmonary Inflammation.

Authors:  Philip M Scherer; Delphine L Chen
Journal:  J Nucl Med       Date:  2016-09-01       Impact factor: 10.057

Review 2.  New therapeutic targets in idiopathic pulmonary fibrosis. Aiming to rein in runaway wound-healing responses.

Authors:  Neil Ahluwalia; Barry S Shea; Andrew M Tager
Journal:  Am J Respir Crit Care Med       Date:  2014-10-15       Impact factor: 21.405

3.  A review of current and novel therapies for idiopathic pulmonary fibrosis.

Authors:  Rokhsara Rafii; Maya M Juarez; Timothy E Albertson; Andrew L Chan
Journal:  J Thorac Dis       Date:  2013-02       Impact factor: 2.895

4.  Safety of octreotide in hospitalized infants.

Authors:  Daniela Testoni; Christoph P Hornik; Megan L Neely; Qinghong Yang; Ann W McMahon; Reese H Clark; P Brian Smith
Journal:  Early Hum Dev       Date:  2015-05-15       Impact factor: 2.699

5.  A machine learning and network framework to discover new indications for small molecules.

Authors:  Coryandar Gilvary; Jamal Elkhader; Neel Madhukar; Claire Henchcliffe; Marcus D Goncalves; Olivier Elemento
Journal:  PLoS Comput Biol       Date:  2020-08-07       Impact factor: 4.475
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.